Henlius Has Denosumab Application Accepted In China

NMPA Also Currently Reviewing Adalimumab And Trastuzumab Filings

 
• By Akriti Seth
  
Compass_Yes
Henlius has had its denosumab filing accepted by China’s NMPA • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products